Viemed Healthcare (VMD) Cash from Financing Activities (2018 - 2026)

Viemed Healthcare has reported Cash from Financing Activities for 9 years, with the latest figure at -$6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 271.19% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at -$10.4 million (down 156.85% YoY), and the FY2025 full-year result was -$5.8 million, down 56.93% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$6.3 million, up from -$8.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $11.3 million in Q2 2023, with the low at -$8.5 million in Q4 2025.
• Historically, Cash from Financing Activities has averaged -$1.7 million across 5 years, with a median of -$2.3 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 301.72% — and 2024, when it slumped 3535.9%.
• Viemed Healthcare's Cash from Financing Activities stood at -$4.9 million in 2022, then jumped by 37.78% to -$3.0 million in 2023, then jumped by 113.33% to $404000.0 in 2024, then tumbled by 2191.83% to -$8.5 million in 2025, then grew by 25.16% to -$6.3 million in 2026.
• The last three Cash from Financing Activities figures came in at -$6.3 million (Q1 2026), -$8.5 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.